APA (7th ed.) Citation

Gong, I. Y., Rafinejad-Farahani, B., Majeed, H., Soto, M. J., Oza, A., Ehrlich, T., . . . Rodin, D. (2026). Reporting and enrollment disparities in hematologic malignancy trials between 2000–2023. Leukemia & Lymphoma, 67(1), 176. https://doi.org/10.1080/10428194.2025.2579735

Chicago Style (17th ed.) Citation

Gong, Inna Y., et al. "Reporting and Enrollment Disparities in Hematologic Malignancy Trials Between 2000–2023." Leukemia & Lymphoma 67, no. 1 (2026): 176. https://doi.org/10.1080/10428194.2025.2579735.

MLA (9th ed.) Citation

Gong, Inna Y., et al. "Reporting and Enrollment Disparities in Hematologic Malignancy Trials Between 2000–2023." Leukemia & Lymphoma, vol. 67, no. 1, 2026, p. 176, https://doi.org/10.1080/10428194.2025.2579735.